Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter
Conditions
Interventions
Surpass Elite with Guardian Flow Diverter System
Locations
10
United States
Carondelet St. Joseph's Hospital
Tucson, Arizona, United States
University of California Davis Health
Davis, California, United States
Stanford University School of Medicine
Palo Alto, California, United States
Lyerly Neurosurgery, an Affiliate of Baptist
Jacksonville, Florida, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
Start Date
June 20, 2025
Primary Completion Date
January 31, 2029
Completion Date
January 31, 2031
Last Updated
April 8, 2026
NCT07518251
NCT07473102
NCT07474935
NCT04246463
NCT03446287
NCT07422129
Lead Sponsor
Stryker Neurovascular
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions